Jorg Wischhusen (University of Würzburg, Würzburg, Germany) presented his work on growth differentiation factor (GDF)-15 (MIC-1) as a tumour immune-suppressive factor and that it could be an effective target for treatment. Here, GDF15 is linked to neoplasm.